research consortium
Mursla Bio, a Cambridge, UK-based company that focuses on EV isolation, biomarker discovery from EV cargo, and EV assays for clinical use, is an EVEREST participant.
HistoIndex Joins Consortium Developing Liver Disease Diagnostic Tool
The consortium, recently funded with €750,000, is developing a computational tool for identifying NAFLD patients at high risk of progressing to NASH.
European CoronaDx Consortium Preparing Three Diagnostic Platforms for COVID-19 Testing
Called CoronaDx, which has a budget of €3 million, aims to facilitate the development of testing systems for use in remote areas with limited infrastructure.
UK Orders 1 Million Abingdon Health Antibody Tests for Surveillance Studies
The test could also be used to assess vaccine effectiveness, should a vaccine become available.
Loop Diagnostics Developing Lateral Flow Test Platform for Sepsis
A consortium led by the Barcelona-based company recently received €150,000 in EU funding to bring the platform to market.
Jun 11, 2019
Feb 2, 2018
Nov 27, 2017
Sep 8, 2016